Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04018157
Other study ID # 5452
Secondary ID
Status Completed
Phase Early Phase 1
First received
Last updated
Start date July 3, 2019
Est. completion date November 23, 2019

Study information

Verified date November 2019
Source Zagazig University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

- emergence agitation is seen in around 68% after nasal surgeries. Agitated patients needs more staff and nurses to control their abnormal movement which leads to self extubation , removal of catheters and bruises in the extremities.

- Dexmedetomidine, ketamine, propofol intravenous infusion and other agents was used to prevent EA . Recently, ketodex is found to reduce the incidence and severity of EA .

- We aim to compare single bolus dose of Ketodex Versus Ketofol For Prevention Of emergence Agitation in adults undergoing nasal surgeries.


Description:

Read more »
Read more »

Study Design


Intervention

Drug:
"Ketamine" and "dexmedetomidine" and "propofol" and "0.9%saline"
patients will receive single intravenous bolus of combination from ketamine 0.5mg/kg and dexmedetomidine 1ug/kg in one syringe diluted in 10 ml 0.9% saline.

Locations

Country Name City State
Egypt Faculty of Medicine Zagazig Elsharkia

Sponsors (1)

Lead Sponsor Collaborator
Zagazig University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of emergence agitation. The incidence of emergence agitation. up to 60 minutes after extubation
Primary The level of emergence agitation. The level of emergence agitation measured by . Richmond Agitation-Sedation scale (RASS) is ten scales; five for sedation level ,one for alertness and calmness, and four for agitation level as follow: -5 unarousable , -4 deep sedation , -3 moderate sedation , -2 light sedation , -1 drowsy ; 0 alert and calm,+1 restless , +2 agitated , +3 very agitated and +4 combative. Patients with score = 2 considered having agitation. up to 60 minutes after extubation
Secondary The Emergence time The time from discontinuation of isoflurane to first response to verbal command. up to 20 minutes after discontinuation of isoflurane
Secondary The extubation time time from discontinuation of isoflurane to extubation. up to 20 minutes after discontinuation of isoflurane
Secondary The time of discharge The time from arrival to postanesthesia care unite (PACU) to discharge to the ward according to modified aldert score up to 40 minutes after extubation
Secondary Postoperative Pain is evaluated using Numerical rating Scale (NRS) (NRS) A commonly used scale is a 10-cm line labeled with "worst pain imaginable" on the right border and "no pain" on the left border. up to 40 minutes after extubation
Secondary "Number of Participants with vomiting or hypotension or bradycardia" vomiting , hypotension, bradycardia Vomiting all over 40 minutes post-operative
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06387953 - Mitigation of Emergence Agitation Through Implementation of Masimo Bridge Therapy N/A
Completed NCT05313659 - Intramuscular Ketamine Effect on Postnasal Surgery Agitation Phase 2
Not yet recruiting NCT05245721 - Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries Phase 1
Recruiting NCT04765488 - WashIn /WashOut Procedure To Prevent Agitation During Recovery After Inhalational Anesthesia With Sevoflurane N/A
Completed NCT04941508 - Mother's Recorded Voice Versus Dexmedetomidine on Postoperative Agitation Phase 3
Completed NCT06339385 - Management of PADIS in Emergency Intensive Care Unit